Helen Davis Bondarenko

Centre Hospitalier de l’Université de Montréal

Papers

4

Total Citations

25

H-Index

4

About

Dr. Helen Davis Bondarenko is a leading urologic surgeon and researcher whose work centers on refining robotic-assisted radical prostatectomy (RARP) to improve outcomes for men with prostate cancer. Her major contributions lie in the rigorous, long-term analysis of surgical techniques and their real-world impact. She led a landmark study on a large Canadian RARP database, reporting oncological and functional outcomes from a decade of surgical experience—a critical contribution given the limited Canadian data on robotic surgery. Dr. Bondarenko also pioneered the use of the AccuVein AV400, an infrared augmented reality device, to reduce abdominal wall hematomas during RARP, directly enhancing patient recovery and satisfaction. Her external validation of the novel ISUP Gleason grading groups in a large Canadian cohort demonstrated the system's strong predictive ability for biochemical recurrence, helping to standardize pathology reporting. Further, she identified key predictors of deviation from planned neurovascular bundle preservation, offering actionable insights to improve functional outcomes. With her papers accumulating over 25 citations, Dr. Bondarenko’s work is foundational for surgeons seeking evidence-based approaches to optimize both cancer control and quality of life.

Research Focus

Key Achievements

4
H-Index
4
Papers
25
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Oncological and functional outcomes of a large Canadian robotic-assisted radical prostatectomy database with 10 years of surgical experience.
8 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Centre Hospitalier de l’Université de Montréal

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago